WHO, Switzerland


Dr Hye-Na Kang is a Scientist of WHO (Switzerland) since Jan 2009 and in charge of development/implementation of guidelines for regulatory evaluation of biologicals including biosimilars. She has organized many workshops and coordinated works to implement the evaluation principles of WHO guidelines into regulatory practices in countries. She is also a member of Biosimilar Working Group of the International Pharmaceutical Regulators Programme.

Prior to joining WHO, she was a scientific officer at Korea Ministry of Food and Drug Safety for twelve years. In 2004, she worked at the Vaccine and Infectious Disease Organization-International Vaccine Center in Canada.


Register for the Biosimilars LatAm – Mexico 2023